Financial Statements/ESG Information - [Interim/Half-Year Report]

Research and development, clinical operations, manufacturing, regulatory communication, business development and commercialization of medical devices.

Interim Report 2024

Announcements and Notices - [Final Results / Other - Miscellaneous]

Supplemental Announcement In Relation To The Annual Report For The Year Ended December 31, 2023

Announcements and Notices - [Interim Results]

Interim Results Announcement For The Six Months Ended June 30, 2024

Announcements and Notices - [List of Directors and their Role and Function]

List Of Directors And Their Roles And Functions

Announcements and Notices - [Change in Directors or of Important Executive Functions or Responsibilities]

Resignation Of Executive Director, Chief Financial Officer And Authorized Representative; Appointment Of Non-Executive
Director; And Appointment Of Authorized Representative

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Interim Report 2024

Supplemental Announcement In Relation To The Annual Report For The Year Ended December 31, 2023

Interim Results Announcement For The Six Months Ended June 30, 2024

List Of Directors And Their Roles And Functions

Resignation Of Executive Director, Chief Financial Officer And Authorized Representative; Appointment Of Non-Executive Director; And Appointment Of Authorized Representative